PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 28500233-0 2017 Nanoformulation of Olaparib Amplifies PARP Inhibition and Sensitizes PTEN/TP53-Deficient Prostate Cancer to Radiation. olaparib 19-27 phosphatase and tensin homolog Mus musculus 69-73 30555227-6 2018 Methods: The tumor cell line 404, which was derived from a Brca2 -/-, Tp53 -/-, Pten -/- genetically engineered mouse model, exhibited high sensitivity to Olaparib in vitro. olaparib 155-163 phosphatase and tensin homolog Mus musculus 80-84 24222661-2 2013 Here, we test the efficacy of AZD2281 (olaparib), an oral PARP inhibitor, in the therapy of PTEN-null endometrial tumors in a preclinical endometrial cancer mouse model. olaparib 30-37 phosphatase and tensin homolog Mus musculus 92-96 24222661-2 2013 Here, we test the efficacy of AZD2281 (olaparib), an oral PARP inhibitor, in the therapy of PTEN-null endometrial tumors in a preclinical endometrial cancer mouse model. olaparib 39-47 phosphatase and tensin homolog Mus musculus 92-96